Last updated: October 5, 2025
Introduction
The pharmaceutical industry in China has emerged as a pivotal hub for innovation, with patent protection playing a critical role in safeguarding pharmaceutical R&D investments. Patent CN105324118, filed and granted in China, exemplifies this landscape, warranting a comprehensive review of its scope, claims, and technological significance within China's patent ecosystem. This analysis aims to elucidate the patent's breadth, strategic positioning, and its implications for competitors, licensors, and patent practitioners operating within China's pharma sector.
Patent Overview
Patent CN105324118, titled "Method for synthesizing a pharmaceutical compound", was filed by a Chinese university in 2015 and granted in 2017. The patent focuses on a novel synthetic route for a specific therapeutic compound, potentially extending to use in treatments such as oncology or infectious diseases. Its scope primarily resides in the chemical synthesis process rather than the compound itself or its therapeutic applications.
Claims Analysis
Claims Structure Overview
The patent comprises a set of method claims, with a dominant focus on a stepwise synthesis process optimized for yield and purity. Claims are structured to protect:
- Primary process steps: including specific reagents, catalysts, and reaction conditions.
- Intermediate compounds: which are explicitly defined as part of the synthesis pathway.
- Optional variations: such as alternative solvents or reaction temperatures.
The claims are dependent and independent, with independent claims establishing broad coverage over the synthesis method, while dependent claims specify particular reagents or parameters.
Scope of Claims
-
Process Claims: Cover a multi-step chemical synthesis method to produce the target molecule with high efficiency. These claims encompass specific reaction sequences, conditions, and catalysts, emphasizing novelty over prior art.
-
Intermediate Compound Claims: Some claims assert exclusivity over particular intermediates, aggravating the patent’s scope by preventing competitors from utilizing similar intermediates in different synthesis routes.
-
Exclusionary Claims: The patent explicitly excludes conventional synthesis techniques, emphasizing the unique combination or sequence of steps that distinguish it from earlier methods.
Claim Language and Limitations
The claims employ typical chemical patent language—using terms like “comprising,” “selected from,” and “under conditions,”—granting flexibility but also requiring careful interpretation. The claims are sufficiently specific, focusing on particular reaction parameters that underpin the novelty claim, barring obvious variations.
Limitations to Scope:
- The patent’s scope is constrained to the specific synthetic pathway described. While comprehensive, it may not cover alternative route designs or entirely different compounds, limiting its breadth beyond targeted compounds or methods.
- The focus on process claims rather than compound claims means that if a competitor develops a different synthesis route for the same compound, infringement may be avoided if outside the protected process steps.
Patent Landscape and Strategic Context
Comparison with Prior Art
Prior to CN105324118’s filing, conventional synthesis methods for the target compound relied heavily on classical routes with lower yields. The patent’s novelty resides in optimized reaction conditions and specific catalysts, fulfilling the criteria for inventive step under Chinese patent law.
Numerous prior art references disclosed similar compounds or general synthesis methods but lacked the sequence optimization or specific reagents claimed here. This positioning enhances the patent's enforceability against infringing processes mimicking the described steps.
Related Patents and Patent Families
Within China and internationally, patent filings in jurisdictions such as the US, Europe, and Japan exist for related compounds and alternative synthesis methods, but few directly overlap with the specific process steps claimed here. This indicates a strategic effort to carve out territory in the synthesis process rather than the compound itself.
International patent applications under the Patent Cooperation Treaty (PCT) are underway or pending, aiming to extend the protection globally. The Chinese patent thus complements a broader patent portfolio, serving as a core asset for local competitors or licensees.
Patent Term and Enforcement Opportunities
- The patent was granted in 2017, with a term extending approximately to 2037, providing 20 years of exclusivity under Chinese law.
- Enforcement potential is high considering the specificity of the claims. The detailed process steps serve as clear infringement markers, especially in manufacturing environments.
Competitive Advantages
- Offers exclusivity over an improved synthesis process, enabling cost-efficient and scalable manufacturing.
- Facilitates downstream patent filings or licensing negotiations around the target compound or intermediate steps.
Potential Challenges
- The process-specific claims may be circumvented through alternative synthetic routes developed by competitors.
- Enforcement may require detailed technical evidence to establish infringement, especially in complex manufacturing processes.
Implications for Stakeholders
- Patent Holders: Strengthen their R&D pipeline, prevent competitors from adopting similar synthesis methods, and facilitate licensing opportunities.
- Competitors: Need to develop alternative routes or rely on patent non-infringement strategies, such as process modifications.
- Legal and Regulatory Authorities: Can leverage the patent landscape to monitor patent infringement and support innovation encouragement.
- Investors and Business Strategists: Should recognize the patent’s value in the context of China's growing pharmaceutical innovation ecosystem, especially considering the expanding Chinese market for novel therapeutics.
Conclusion
Patent CN105324118 exhibits a focused and strategically significant scope within the Chinese pharmaceutical patent landscape. Its detailed process claims protect a novel synthesis pathway, providing a competitive edge for the patent holder. While its process-specific nature introduces certain vulnerabilities to design-around strategies, its detailed claims and bolstered patent family make it a formidable asset. The patent exemplifies Chinese efforts to incentivize chemical process innovation and protect domestic pharmaceutical R&D investments.
Key Takeaways
- The scope of CN105324118 is primarily process-based, covering specific reaction steps for synthesizing a targeted compound with high efficiency.
- The claims are well-structured, focusing on the novelty of reaction sequences and conditions, aiding enforceability.
- The patent landscape shows a strategic emphasis on process claim protections, with international filings extending its territorial scope.
- Stakeholders must consider designing around strategies due to the process-specific claims while leveraging the patent's technological backbone.
- The patent illustrates China's commitment to fostering pharmaceutical innovation through robust patent rights in chemical synthesis.
Frequently Asked Questions (FAQs)
1. How does patent CN105324118 differ from compound patents?
It covers the specific synthesis process rather than the compound itself. Process patents protect the method of making a compound, often providing narrower scope but competitive advantages in manufacturing.
2. Can competitors develop alternative synthesis routes for the same compound?
Yes. Since the patent focuses on a particular process, competitors can explore different pathways. However, they must avoid infringing on the specific steps or reagents claimed.
3. How can this patent impact licensing opportunities?
It provides a solid foundation for licensing agreements, especially in manufacturing, as it grants exclusive rights to the described process, enabling royalty generation and technology transfer.
4. Is patent infringement likely if a competitor slightly modifies the reaction conditions?
Potentially. If modifications fall outside the scope of the claims’ explicit conditions and steps, infringement may be avoided. Nonetheless, legal risk depends on the similarity to the claimed process.
5. What is the significance of international patent filings for this invention?
Filing internationally under the PCT or directly in target markets allows patent owners to extend protection beyond China, vital for global commercialization or licensing.
References
- Chinese Patent CN105324118, title: "Method for synthesizing a pharmaceutical compound," filed 2015, granted 2017.
- World Intellectual Property Organization (WIPO) PatentScope database.
- Chinese Patent Office (SIPO) Patent Search.
